Modulation of quail intestinal and egg shell gland calbindin (Mr 28,000) gene expression by vitamin D3, 1,25-dihydroxyvitamin D3 and egg laying.
The effects of vitamin D3 sources, egg production and egg cycle on the genomic expression of calbindin (Mr 28,000) in the intestine and egg shell gland (ESG) of quail were characterized by Northern blot and solution hybridization, using synthetic oligonucleotide probe. In vitamin D3- or 1,25-dihydroxyvitamin D3 (1,25-(OH)2D3)-fed quail, onset of egg production induced duodenal and ESG calbindin mRNA and calbindin synthesis. Duodenal calbindin mRNA was slightly higher during the period of shell calcification as compared with the period during which shells were not formed (ESG inactivity). ESG calbindin mRNA was markedly higher during the period of shell calcification than of ESG inactivity. Increasing dietary intake of [3H]1 alpha-hydroxyvitamin D3 increased the duodenal, but not ESG, content of 1,25-(OH)2D3 and calbindin. Duodenal calbindin and its mRNA were absent in vitamin D-deficient quail and were not affected by egg laying. ESG calbindin in the vitamin D-deficient quail was not affected by egg laying, but calbindin mRNA increased in the vitamin D-deficient birds during shell calcification. The results suggest that: (a) intestinal calbindin mRNA and calbindin are induced and/or regulated, either directly or indirectly, by 1,25-(OH)2D3; (b) intestinal calbindin and its mRNA are further induced at the onset of egg laying by an additional stimulator besides 1,25-(OH)2D3; (c) 1,25-(OH)2D3 is required for the expression of the latter stimulator; (d) ESG calbindin mRNA and calbindin are induced in egg-laying birds by a stimulator associated with the egg cycle; and (e) the induction of ESG calbindin mRNA does not need vitamin D metabolites, but 1,25-(OH)2D3 is required for the translation of the mRNA.
Striem
S
S
Institute of Animal Science, ARO, Volcani Center, Bet Dagan, Israel.
Bar
A
A
D000818:Animals; D064026:Calbindins; D002117:Calcitriol / Q000494:pharmacology*; D002762:Cholecalciferol / Q000494:pharmacology*; D004386:Duodenum / Q000378:metabolism*; D005260:Female; D005786:Gene Expression Regulation / Q000187:drug effects; D010057:Oviducts / Q000378:metabolism*; D010058:Oviposition / Q000502:physiology*; D011784:Quail / Q000378:metabolism*; D012333:RNA, Messenger / Q000096:biosynthesis; D064030:S100 Calcium Binding Protein G / Q000096:biosynthesis* / Q000235:genetics; D014808:Vitamin D Deficiency / Q000378:metabolism
D064026:Calbindins; D012333:RNA, Messenger; D064030:S100 Calcium Binding Protein G; D002762:Cholecalciferol; D002117:Calcitriol